The introduction in July of a new payment system in hospitals in Abu Dhabi, designed to steer patients more towards state-owned hospitals and away from private clinics such as those operated by Mediclinic International, is one of those known facts that the market really should have taken cognisance of, but it seems to be largely behind a 144p fall in the share price to 776p.
The shares are a notoriously volatile performer despite half of them being tradeable on the market. The company is one of the least well known in the FTSE 100, having been created in February by the reverse of Mediclinic of South Africa into the London-quoted Al Noor. It runs clinics in the United Arab Emirates, southern Africa and Switzerland